Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of pharmaceutical composition for treating mammary gland hyperplasia and its preparation method and application

A breast hyperplasia and composition technology, which is applied in the directions of drug combinations, pharmaceutical formulations, medical preparations containing active ingredients, etc., can solve problems such as aggravation of symptoms, difficulty in curing, mental depression, etc., and achieve high efficiency and relieve breast pain. Effect

Active Publication Date: 2019-01-29
CHENGDU COMFAITH PHARMA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is easy to attract attention, and it is often difficult to cure. If it is not cured for a long time, it will cause mental depression and aggravate symptoms

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of pharmaceutical composition for treating mammary gland hyperplasia and its preparation method and application
  • A kind of pharmaceutical composition for treating mammary gland hyperplasia and its preparation method and application
  • A kind of pharmaceutical composition for treating mammary gland hyperplasia and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] The preparation of embodiment 1 composition of the present invention

[0023] Baizhi 10g, Bupleurum 6g, Fried Atractylodes 15g, Angelica 6g, Calcined oyster 20g, Curcuma 8g, Poria cocos 15g, Guizhi 6g, Seaweed 12g, Magnolia officinalis 10g, Astragalus 12g, Huoxiang 8g, Tangerine core 10g, Kelp 12g, Longan Gall grass 5g, myrrh 5g, frankincense 3g, trigonum 8g, cohosh 5g, water safflower seed 15g, leech 4g, loofah 15g, peach kernel 8g, stevia 10g, wulingzhi 6g, prunella vulgaris 8g, scrophulariaceae 15g, dried blood 3g, Fritillaria 12g.

[0024] Take the above-mentioned raw materials, add water to decoct 3 times, decoct for 30 minutes each time, and combine the decoctions to obtain the decoction.

Embodiment 2

[0025] The preparation of embodiment 2 compositions of the present invention

[0026] Baizhi 7g, Bupleurum 3g, Stir-fried Atractylodes macrocephala 12g, Angelica 3g, Calcined oyster 17g, Curcuma 5g, Poria cocos 12g, Guizhi 3g, Seaweed 9g, Magnolia officinalis 7-13g, Astragalus 9g, Huoxiang 5g, Orange core 7g, Kelp 9g , gentian 2g, myrrh 2g, frankincense 2g, trigonum 5g, cohosh 2g, water safflower seed 12g, leech 2g, loofah 12g, peach kernel 5g, stevia 7g, wulingzhi 3g, prunella vulgaris 5g, Scrophulariaceae 12g, dried blood 2g, Fritillaria 9g.

[0027] Take the above-mentioned crude drug, dry each component and pulverize it, sieve the drug powder with a certain particle size, mix it evenly, and make tea bag or powder, each bag contains 2g.

Embodiment 3

[0028] The preparation of embodiment 3 compositions of the present invention

[0029] Take raw materials: Angelica dahurica 13g, Bupleurum 9g, fried Atractylodes macrocephala 18g, angelica 9g, calcined oyster 23g, curcuma 11g, Poria cocos 18g, cassia twig 9g, seaweed 15g, magnolia officinalis 13g, astragalus 15g, Huoxiang 11g, orange core 13g, 15g kelp, 8g gentian, 8g myrrh, 4g frankincense, 11g trigonum, 8g cohosh, 18g water safflower seed, 6g leech, 18g loofah, 11g peach kernel, 13g stevia, 9g Wulingzhi, Prunella vulgaris 11g, Scrophulariaceae 18g, Dried Blood 4g, Fritillaria 15g.

[0030] Take the above-mentioned raw material drug, add water to decoct 3 times, decoct for 30 minutes each time, combine the decoction, concentrate, stand still, take the supernatant, concentrate again, add appropriate amount of auxiliary materials, and prepare ointment, oral liquid or syrup.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating hyperplasia of mammary glands. The pharmaceutical composition is a preparation prepared from the following raw materials in parts by weight: 5-15 parts of angelica dahurica, 1-11 parts of radix bupleuri, 10-20 parts of roasted atractylodes macrocephala, 1-11 parts of angelica, 15-25 parts of calcined oyster shell, 3-13 parts of zedoary, 10-20 parts of poria cocos, 1-11 parts of cassia twig, 7-17 parts of seaweed, 5-15 parts of mangnolia officinalis, 7-17 parts of hoantchy root, 3-13 parts of agastache, 5-15 parts of tangerine seeds, 7-17 parts of kelp, 1-9 parts of gentian, 1-9 parts of myrrh, 1-5 parts of frankincense, 3-13 parts of rhizoma sparganii, 1-9 parts of rhizoma cimicifugae, 10-20 parts of fructus polygoni orientalis, 1-7 parts of leeches, 10-20 parts of loofah sponge, 3-13 parts of peach kernels, 5-15 parts of stevia rebaudiana, 1-11 parts of excrementum pteropi, 3-13 parts of selfheal, 10-20 parts of figwort root, 1-5 parts of dragon's blood and 7-17 parts of fritillary bulb. The pharmaceutical composition provided by the invention can effectively relieve breast pain, breast lumps, nipple discharge, menstrual disorder, emotion alteration and other symptoms of hyperplasia of mammary glands, has a high effective rate, can be used for treating I-phase hyperplasia, II-phase hyperplasia and III-phase hyperplasia of mammary glands, and provides a new clinical medicine choice.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating mammary gland hyperplasia, its preparation method and application. Background technique [0002] Mammary gland hyperplasia refers to hyperplasia of mammary gland epithelium and fibrous tissue, structural degeneration of breast tissue ducts and lobules, and progressive growth of connective tissue. Hyperplasia of mammary glands is a common gynecological disease, and it often occurs in middle-aged women aged 25-39, because this period is the most vigorous period of female sexual function, manifested as single or multiple growths of lumps in different parts of the breast , soft texture, unclear boundary, movable, often accompanied by different degrees of pain, especially before menstruation, after fatigue, or when mood swings such as anger (called qi depression in traditional Chinese medicine), the mass increases and the pain worsens, while during menstruation Afterwards, the mass shrunk s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9066A61P15/14A61P15/00A61P29/00A61K35/24A61K35/618A61K35/62
Inventor 夏隆江何宇新刘蓓李昌龙张翠媚蔡玉贵吴彬
Owner CHENGDU COMFAITH PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com